The Vistria Group and Excellere Partners completed the acquisition of SCA Pharmaceuticals from Enhanced Healthcare Partners.

Private equity firms The Vistria Group and Excellere Partners, completed the acquisition of SCA Pharmaceuticals, a pharmaceutical company, from Enhanced Healthcare Partners, a healthcare-focused private equity firm. Financial terms were not disclosed. “We are very pleased that as we continue our expansion efforts and improvements in our efficiencies, our new partnership with The Vistria Group and Excellere will allow us to accelerate these efforts. Both partners recognize the unprecedented growth that we have achieved and are committed to fast-tracking our expansion and automation goals," Milton Boyer, SCA Pharma CEO.